金石亚药：全资二级子公司收到《药品补充申请批准通知书》

Core Viewpoint - The company, Jinsiyaya Pharmaceutical, announced that its subsidiary, Zhejiang Deer Pharmaceutical, has received approval from the National Medical Products Administration for its Diclofenac Sodium Sustained-release Tablets (0.1g) after passing the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - Jinsiyaya Pharmaceutical's subsidiary, Zhejiang Deer Pharmaceutical, is a wholly-owned secondary subsidiary [1] - The approval notification number for the drug is 2025B05105 [1] - The drug is a sustained-release formulation of Diclofenac Sodium [1]